Submit an Article
Online ISSN: 1945-4589
Impact Journals, LLC. is the publisher of Aging: www.impactjournals.com.
Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.
Impact Journals is a member of the Society for Scholarly Publishing.
Learn about our FREE Post-Publication Promotion Services
Editorial Volume 8, Issue 8 pp 1576—1577

Evolution of resistance to thyroid cancer therapy

Carmelo Nucera1,2, ,

  • 1 Laboratory of human thyroid cancers preclinical and translational research, Division of Experimental Pathology, Cancer Research Institute (CRI), Cancer Center, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
  • 2 Department of Pathology, Center for Vascular Biology Research (CVBR), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA

Received: August 3, 2016       Published: August 27, 2016      

https://doi.org/10.18632/aging.101030
How to Cite
Download PDF
Corresponding Author

Carmelo Nucera
cnucera@bidmc.harvard.edu

Keywords
BRAFV600E papillary thyroid cancer pre-clinical model BRAFV600E inhibitors resistance MCL1 somatic copy number clonal evolution microenvironment